In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Summit Autonomous Inc.

Division of Nestle SA
www.sum-tech.com

Latest From Summit Autonomous Inc.

Avedro Financing Highlights New Ophthalmology Market

In early July, ophthalmology start-up Avedro closed a $25 million Series C round. In a refractive surgery market where, apart from laser cataract surgery, there hasn't been much new to speak of in years, Avedro has a potentially disruptive technology, although the company plans not to disrupt as much as to grow the market.
Medical Device

Carl Zeiss Steps Up in Ophthalmics

Long part of a German foundation dedicated to improving optical science, Carl Zeiss Meditec has transformed itself into a more entrepreneurial entity, hoping to capitalize on the booming ophthalmics market. For Zeiss, the timing couldn't be better--driven by soaring demographics and new technology, the industry is hot. Plus an industry ripe for consolidation plays well into Zeiss' plans. The only question is: does Zeiss' foundation heritage help or hinder its efforts?
Medical Device

Self-Pay Medicine: A Strategy or Fall Back?

More concerned about quality-of-life issues than insurers, many consumers will gladly pay out-of-pocket for some products if they relieve chronic conditions that inconvenience or disable them. The success of products such as Lasik vision correction surgery and non-sedating antihistamines and the growing market for alternative medicine suggest that consumers are open to, and in some cases, eager for a wide array of products shunned by traditional care insurers. But marketing directly to consumers is not enough--physicians, insurers, and even hospitals have to be brought into the loop..
BioPharmaceutical Medical Device

Deal Statistics Quarterly, Q2 2000

In Vivo introduces a new quarterly feature, a statistical review compiled from our Strategic Transactions database. In this edition, we include financings by type (IPO, private placement etc.); financings by sector (surgical equipment, implantable devices, etc.); alliances by therapeutic category (cardiovascular, orthopedic, etc.); alliances by industry segment (biomaterials, monitoring equipment, etc. ); for three separate industries: medical devices, in vitro diagnostics, and pharmaceuticals/biotechnology.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Ophthalmic > Vision Correction
  • Alias(es)
  • Summit Technology Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nestle SA
  • Senior Management
  • Contact Info
  • Summit Autonomous Inc.
    Phone: (781) 890-1234
    21 Hickory Drive
    Waltham, MA 02154
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register